The report focuses on the 23-Valent Pneumococcal Polysaccharide Vaccine market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the 23-Valent Pneumococcal Polysaccharide Vaccine market.
Major Players in the 23-Valent Pneumococcal Polysaccharide Vaccine market are:
Biogen Inc.
Sanofi S.A.
Pfizer Inc.
AstraZeneca
Serum Institute of India
Baxter International Inc.
GlaxoSmithKline Plc
Beijing Minhai Biotechnology
Merck & Co.
Eli Lilly and Company
On the basis of types, the 23-Valent Pneumococcal Polysaccharide Vaccine market is primarily split into:
Single Dose Vial
Pre-filled Syringe
On the basis of applications, the market covers:
For Children (2-10)
For Person (10-64)
For The old (?65)
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine Market
1.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Type
1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment by Application
1.3.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of 23-Valent Pneumococcal Polysaccharide Vaccine (2017-2029)
1.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue Status and Outlook (2017-2029)
1.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the 23-Valent Pneumococcal Polysaccharide Vaccine Industry
1.7 Impact of Carbon Neutrality on the 23-Valent Pneumococcal Polysaccharide Vaccine Industry
2 23-Valent Pneumococcal Polysaccharide Vaccine Market Upstream and Downstream Analysis
2.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Biogen Inc.
3.1.1 Biogen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Sanofi S.A.
3.2.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Pfizer Inc.
3.3.1 Pfizer Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.3.4 Business Overview
3.4 AstraZeneca
3.4.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Serum Institute of India
3.5.1 Serum Institute of India Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Baxter International Inc.
3.6.1 Baxter International Inc. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.6.4 Business Overview
3.7 GlaxoSmithKline Plc
3.7.1 GlaxoSmithKline Plc Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Beijing Minhai Biotechnology
3.8.1 Beijing Minhai Biotechnology Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Merck & Co.
3.9.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Eli Lilly and Company
3.10.1 Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Performance (2017-2022)
3.10.4 Business Overview
4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Landscape by Player
4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Share by Player (2017-2022)
4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Player (2017-2022)
4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Player (2017-2022)
4.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Gross Margin by Player (2017-2022)
4.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
4.5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
4.5.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price Trend by Type
5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2017-2022)
5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2017-2022)
5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2022)
5.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate of Single Dose Vial (2017-2022)
5.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Growth Rate of Pre-filled Syringe (2017-2022)
6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis by Application
6.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Market Share by Application (2017-2022)
6.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate of For Children (2-10) (2017-2022)
6.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate of For Person (10-64) (2017-2022)
6.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate of For The old (?65) (2017-2022)
7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Region Wise (2017-2022)
7.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share, Region Wise (2017-2022)
7.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share, Region Wise (2017-2022)
7.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2022-2029)
8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue Forecast (2022-2029)
8.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price and Trend Forecast (2022-2029)
8.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.5 India 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue Forecast (2022-2029)
8.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate of Single Dose Vial (2022-2029)
8.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate of Pre-filled Syringe (2022-2029)
8.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2022-2029)
8.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Growth Rate of For Children (2-10) (2022-2029)
8.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Growth Rate of For Person (10-64) (2022-2029)
8.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Value and Growth Rate of For The old (?65) (2022-2029)
8.5 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast Under COVID-19
9 Industry Outlook
9.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers Analysis
9.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints and Challenges
9.3 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 23-Valent Pneumococcal Polysaccharide Vaccine Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 23-Valent Pneumococcal Polysaccharide Vaccine Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on 23-Valent Pneumococcal Polysaccharide Vaccine Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global H1N1 Vaccines Market Insights, Forecast to 2029
Published: 30-May-2023 Price: US 4900 Onwards Pages: 110
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
The global H1N1 Vaccines market is projected to grow from US$ 4739.1 million in 2023 to US$ 5708.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period.
The global H1N1 vaccination market is anticipated to boost in the focus perio......
Global Avian Influenza Vaccines Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 11-May-2023 Price: US 3260 Onwards Pages: 111
Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred.
The Avian Influenza Vaccines market revenue was 933.69 Million USD in 2022, and will reach 1586.45 Million USD in 2028, with a CAGR......
Global Meningococcal Vaccines Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 25-Apr-2023 Price: US 3260 Onwards Pages: 95
The Meningococcal Vaccines market revenue was 4612.21 Million USD in 2022, and will reach 10398.15 Million USD in 2028, with a CAGR of 14.51% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Meningococcal Vaccines industry, and breaks down according to the type, application, and consumption area of Meningococcal Vaccines. The report also introduces players in the industry from the perspective of the industry chain and marke......
Global Meningococcal Conjugate Market Research Report 2023
Published: 11-Apr-2023 Price: US 2900 Onwards Pages: 93
Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease.
Highlights
The global Meningococcal Conjugate market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during t......
Global Influenza Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 11-Apr-2023 Price: US 3260 Onwards Pages: 112
Influenza Vaccine are vaccines that protect against infection by influenza viruses.
The Influenza Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Influenza Vaccine industry, and breaks down according to the type, application, and consumption area of Influenza Vaccine. The report also introduces players in the......
2023-2031 Report on Global Encephalitis Vaccination Market by Player, Region, Type, Application and Sales Channel
Published: 13-Mar-2023 Price: US 2500 Onwards Pages: 92
This report studies the Encephalitis Vaccination market, covering market size for segment by type (Encephalitis B Vaccine, Encephalitis Attenuated Live Vaccine, etc.), by application (Hospitals, Other Medical Institutions, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Novartis, Sanofi, Chengdu institute of biologica, Wuhan Institute of Biological, Lanzhou Institute of Biological, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East ......
2023-2031 Report on Global Avian Influenza Vaccines Market by Player, Region, Type, Application and Sales Channel
Published: 13-Mar-2023 Price: US 2500 Onwards Pages: 87
This report studies the Avian Influenza Vaccines market, covering market size for segment by type (Type H5, Type H9, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, CEVA, Zoetis, Elanco (Lohmann), Merck Animal Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Avian Influenza ......
Global H1N1 Vaccines Market Research Report 2023
Published: 07-Mar-2023 Price: US 2900 Onwards Pages: 90
A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
Highlights
The global H1N1 Vaccines market was valued at US$ 4576.4 million in 2022 and is anticipated to reach US$ 5708.3 million by 2029, witnessing a CAGR of 3.2% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were co......
Global Pneumococcal Polysaccharide Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 02-Mar-2023 Price: US 3260 Onwards Pages: 95
The Pneumococcal Polysaccharide Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Pneumococcal Polysaccharide Vaccine industry, and breaks down according to the type, application, and consumption area of Pneumococcal Polysaccharide Vaccine. The report also introduces players in the industry from the perspective of the......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
